Reed Jobs’s Yosemite raises $350 million second fund to make cancer non-lethal
Friday, November 6, 2026 · first reported by Fortune
Yosemite, the cancer-focused venture firm founded by Reed Jobs, has closed its second fund at $350 million, up from a first close of $200 million in January. Jobs told Fortune and the Term Sheet Podcast of the close. Limited partners include Amgen, AbbVie, MIT, Memorial Sloan Kettering and John Doerr.
The firm invests in early-stage startups and also gives philanthropic grants to scientists. Its first fund closed in 2024 at $263 million. Yosemite spun out of Laurene Powell Jobs's Emerson Collective in 2023.
- Firm
- Yosemite
- Fund
- Yosemite Fund II
- Size
- $350M
- Stage
- Close
- People
- Reed Jobs
- Asset class
- Venture
- Geography
- North America
The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.
See an error?
Coverage
1 source- Israel’s Clalit, Schneider children’s hospital launch $50M venture fund for pediatric healtheJewishPhilanthropy
- The ex-Secret Service agent who flipped a hacker is now raising a second $250M cybersecurity fundTechCrunch
- Oman’s Phaze Ventures gathers $40m toward $75m AI fund platformPEI Private Equity
- Flashpoint closes $116M fourth venture growth fund for European, Israeli AIDealroom +1
- Investment firm Denmu closes oversubscribed debut fund, surpassing $50 million targetgamesindustry.biz +1
- IA Capital Group Announces Initial Close of Inter-Atlantic Opportunity Fund I, Anchored by QBE Insurance GroupYahoo Finance +4
Got news? Send it to us →